FDMT vs TEAM · rev $37.0K vs rev $6.57B
4D Molecular Therapeutics Inc (FDMT) versus Atlassian Corp Plc (TEAM) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Atlassian Corp Plc (TEAM) is a software - application company listed on NASDAQ. It is led by Mike Cannon-Brookes.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported TEAM revenue for 2026-06-30 was $6.57B. Net income was -$53.8M. Revenue was up 26.0% from 2025-06-30 to 2026-06-30. TEAM currently screens at market cap $22.01B.
FDMT currently screens at market cap $518.1M. TEAM currently screens at market cap $22.01B.
Not investment advice. Open the FDMT and TEAM stock pages for the full models.
Not investment advice.